扩张型心肌病合并慢性心力衰竭是心肌炎晚期的主要结局。近年来，对心肌炎的诊断与治疗方面的研究有一点的新进展，无辐射的CMR检查对VMC的诊断有着重大的价值，但是不能够替代心内膜下心肌组织活检。心肌炎的治疗主要是对症辅助支持处理，主要为积极治疗患者休克、心功能的不全及严重的心律失常等综合治疗。因目前缺乏大量的相关临床研究数据，对于心肌炎的诊治仍需进一步探索。

　　参考文献：

　　[1]Baughman KL.Diagnosis of myocarditis: death of Dallas criteria.Circulation2006;113:593-595.

　　[2]Lieberman EB,Hutchins GM,Herskowitz A'et al.Clinicopathologic descriptionof myocarditis J. J Am Coll Cardiol, 1991; 18（7）： 1671-1626.

　　[3]汪翼。小儿暴发性心肌炎的诊断与病原治疗[J].小儿急救医学，2003;10（3）；129-130.

　　[4]Richardson P,McKenna W,Bristow M,et al. Report of the 1995 World HealthOrganization/International Society and Federation of Cardiology Task Force onthe Definition and Classification of Cardiomyopathies.Circulation,1996;93:841-842.

　　[5]中华医学会儿科学会心血管组。病毒性心肌炎诊断标准[J].中华儿科杂志，2000;38（2）：75-76.

　　[6] Nishii M,Inomata T,Takehana H,et al.Serum levels of interleukin-10 onadmission as a prognostic predictor of human fulminant myocarditis. J Am ollCardiol,2004;44:1292-1297.

　　[7] Smith SC,Ladenson JH,Mason JW,et al.Elevations of cardiac troponin Iassociated with myocarditis. Experimental and clinical correlates.Circulation, 1997;95:163-168.

　　[8]Soongswang J,Durongpisitkul K,Nana A,et al.Cardiac troponin T: a marker inthe diagnosis of acute myocarditis in children. Pediatr Cardiol,2005;26:45-49.

　　[9] Dao Q,Krishnaswamy P,Kazanergrar,et al.B-type natriureti. C petide indiagnosis of congestive heart failure in an urgent care setting[J].J AM CollCardiol,2001;37:379-385.

　　[10] Bay M?Kirk V,Pmer J,et al.NT-pro BNP:a new diagnostic screening tool todiffenmfiate bt31woo patients with lloftntd and reduced left ventrieularsystoliction[J].Heart?2003;89（2）： 150-154.

　　[11] Robert D,Harry J,Crijns,et al.Acute viral myocarditis. European HeartJournal,2008;29:2073-2082.

　　[12]Kuhlu,Pauschingerm,Seebergb,et al.Viral persistence in the myocardium isassociated with progressive cardiac dysfunction[J] .Circulation,2005 ; 112（ 13）：1965-1970.

　　[13] Nakashima H,Katayama TJshizaki M,et al.Q wave and non-Q wavemyocarditis with special reference to clinical significance. Jpn Heart J,1998;39:763-774.

　　[14]Magnani JW, Danik HJ,Dec JR, et al. Survival in biopsy-proven myocarditis:a long-term retrospective analysis of the histopathologic,clinical,andhemodynamic predictors[J]. Am Heart J,2006; 151 （2）：463-470.

　　[15] Ukena C5Mahfoud F,Kindermann I,et al.Prognostic electrocardiographicparameters in patients with suspected myocarditis.Eur J Heart Fail,2011;13:398-405.

　　[16] Felker GM,Boehmer JP,Hruban RH,et al.Echocardiographic findings infulminant and acute myocarditis.J Am Coll Cardiol,2000;36:227_232.

　　[17]Abdel-Aty H,Simonetti O,Friedrich MG. T2-weighted cardiovascularmagnetic resonance imaging [J].J Magn Reson Imaging, 2007;26（3）：452-459.

　　[18]Abdel-Aty H,Boye P, Zagrosek A,et al. Diagnostic performance ofcardiovascular magnetic resonance in patients with suspected acute myocarditis:comparison of different approaches. J Am Coll Cardiol, 2005;45:1815-22.

　　[19]Skouri HN,Dec GW,Friedrich MG, et al. Nonivasive imaging in myocarditis.J Am Coll Cardiol, 2006;48（10）：2085-2093.

　　[20]Friedrich MG,Sechtem U,Schulz MJ,et al.Cardiovascular magnetic resonancein myocarditis: a JACC White Paper. J Am Coll Cardiol,2009;53:1475-1487.

　　[21] Mewton N,Liu CY,Croisille P,et al. Assessment of myocardial fibrosis withcardiovascular magnetic resonance. J Am Coll Cardiol, 2011;57（8）：891-903.

　　[22]Zhao SH.Recommendations for CMR in adults with CHD from the respectiveworking groups of the ESC:explanation and viewpoint.Chin J Magn ResonImaging,2010;1,4.

　　[23]Aretz HT. Myocarditis: the Dallas criteria. Hum Pathol, 1987; 18:619-624.

　　[24]Baughman KL.Diagnosis of myocarditisideath of Dallas criteria. Circulation,2006;113:593-595.

　　[25] Yilmaz A,Kindermann I,Kindermann M,et al. Comparative evaluation ofleft and right ventricular endomyocardial biopsy: differences in complication rateand diagnostic performance. Circulation?2010; 122:900-909.

　　[26] Kindermann I, Kindermann M,Kandolf R,et al. Predictors of outcome inpatients with suspected myocarditis. Circulation,2008;l 18:639-648.

　　[27]Dickstein K,Cohen SA,Filippatos G,et al. ESC Guidelines for the diagnosisand treatment of acute and chronic heart failure 2008: the Task Force for theDiagnosis and Treatment of Acute and Chronic Heart Failure 2008 of theEuropean Society of Cardiology. Eur Heart J?2008;29:2388-2442.